562 related articles for article (PubMed ID: 21750460)
1. A prospective randomized double-blinded pilot study to examine the effect of botulinum toxin type A injection versus Lidocaine/Depomedrol injection on residual and phantom limb pain: initial report.
Wu H; Sultana R; Taylor KB; Szabo A
Clin J Pain; 2012 Feb; 28(2):108-12. PubMed ID: 21750460
[TBL] [Abstract][Full Text] [Related]
2. Intradermal botulinum toxin type A injection effectively reduces residual limb hyperhidrosis in amputees: a case series.
Charrow A; DiFazio M; Foster L; Pasquina PF; Tsao JW
Arch Phys Med Rehabil; 2008 Jul; 89(7):1407-9. PubMed ID: 18586144
[TBL] [Abstract][Full Text] [Related]
3. Comparison Between Steroid and 2 Different Sites of Botulinum Toxin Injection in the Treatment of Lateral Epicondylalgia: A Randomized, Double-Blind, Active Drug-Controlled Pilot Study.
Guo YH; Kuan TS; Chen KL; Lien WC; Hsieh PC; Hsieh IC; Chiu SH; Lin YC
Arch Phys Med Rehabil; 2017 Jan; 98(1):36-42. PubMed ID: 27666156
[TBL] [Abstract][Full Text] [Related]
4. The contribution of sympathetic mechanisms to postamputation phantom and residual limb pain: a pilot study.
Cohen SP; Gambel JM; Raja SN; Galvagno S
J Pain; 2011 Aug; 12(8):859-67. PubMed ID: 21481650
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C
J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
[TBL] [Abstract][Full Text] [Related]
6. Concordance of Phantom and Residual Limb Pain Phenotypes in Double Amputees: Evidence for the Contribution of Distinct and Common Individual Factors.
Streit F; Bekrater-Bodmann R; Diers M; Reinhard I; Frank J; Wüst S; Seltzer Z; Flor H; Rietschel M
J Pain; 2015 Dec; 16(12):1377-1385. PubMed ID: 26431882
[TBL] [Abstract][Full Text] [Related]
7. [Long-term treatment of phantom- and stump pain with Botulinum toxin type A over 12 months. A first clinical observation].
Kern U; Martin C; Scheicher S; Müller H
Nervenarzt; 2004 Apr; 75(4):336-40. PubMed ID: 15176410
[TBL] [Abstract][Full Text] [Related]
8. The role of afferent input in postamputation pain: a randomized, double-blind, placebo-controlled crossover study.
Buch NS; Ahlburg P; Haroutounian S; Andersen NT; Finnerup NB; Nikolajsen L
Pain; 2019 Jul; 160(7):1622-1633. PubMed ID: 30817438
[TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin A Injections Into Pelvic Floor Muscles Under Electromyographic Guidance for Women With Refractory High-Tone Pelvic Floor Dysfunction: A 6-Month Prospective Pilot Study.
Morrissey D; El-Khawand D; Ginzburg N; Wehbe S; O'Hare P; Whitmore K
Female Pelvic Med Reconstr Surg; 2015; 21(5):277-82. PubMed ID: 25900057
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of belladonna and opiate suppository during intravesical onabotulinum toxin A injection.
LeClaire EL; Duong J; Wykes RM; Miller KE; Winterton TL; Bimali M
Am J Obstet Gynecol; 2018 Nov; 219(5):488.e1-488.e7. PubMed ID: 29902447
[TBL] [Abstract][Full Text] [Related]
11. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
12. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y
Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
[TBL] [Abstract][Full Text] [Related]
13. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.
Gassner HG; Sherris DA
Mayo Clin Proc; 2000 Jul; 75(7):701-4. PubMed ID: 10907385
[TBL] [Abstract][Full Text] [Related]
14. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Kuo HC; Jiang YH; Tsai YC; Kuo YC
Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
[TBL] [Abstract][Full Text] [Related]
15. [Effect of botulinum toxin type B on residual limb sweating and pain. Is there a chance for indirect phantom pain reduction by improved prosthesis use?].
Kern KU; Kohl M; Seifert U; Schlereth T
Schmerz; 2012 Apr; 26(2):176-84. PubMed ID: 22527647
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin therapy for management of phantom and residual limb pain following amputation: A systematic review.
Frengopoulos C; Neferu R; Pasquali M; Viana R; Miller T; Payne M
Prosthet Orthot Int; 2024 Mar; ():. PubMed ID: 38517393
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin a does not decrease calf pain or improve ROM during limb lengthening: a randomized trial.
Lee DH; Ryu KJ; Shin DE; Kim HW
Clin Orthop Relat Res; 2014 Dec; 472(12):3835-41. PubMed ID: 24604111
[TBL] [Abstract][Full Text] [Related]
18. Effects of botulinum toxin type B on stump pain and involuntary movements of the stump.
Kern U; Martin C; Scheicher S; Müller H
Am J Phys Med Rehabil; 2004 May; 83(5):396-9. PubMed ID: 15100632
[TBL] [Abstract][Full Text] [Related]
19. Protective and Risk Factors for Phantom Limb Pain and Residual Limb Pain Severity.
Münger M; Pinto CB; Pacheco-Barrios K; Duarte D; Enes Gunduz M; Simis M; Battistella LR; Fregni F
Pain Pract; 2020 Jul; 20(6):578-587. PubMed ID: 32176435
[TBL] [Abstract][Full Text] [Related]
20. Analgesic effects of intravenous lidocaine and morphine on postamputation pain: a randomized double-blind, active placebo-controlled, crossover trial.
Wu CL; Tella P; Staats PS; Vaslav R; Kazim DA; Wesselmann U; Raja SN
Anesthesiology; 2002 Apr; 96(4):841-8. PubMed ID: 11964590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
